Author:
Kwakernaak Roel Christian,Brand Victor J.,Rojo Santiago Jesús,Froklage Femke E.,Hoogeman Mischa,Habraken Steven JM,Milder Maaike
Reference42 articles.
1. How low is the alpha/beta ratio for prostate cancer?;J Z Wang;Int J Radiat Oncol Biol Phys,2003
2. A Multicenter Phase 2 study of Hypofractionated Stereostatic Boost in Intermediate Risk Prostate Carcinoma: A 5-Year Analysis of the CKNO-PRO Trial;D Pasquier;International Journal of Radiation Oncology,2020
3. Patient-reported quality of life after stereotactic body radiotherapy (SBRT), intensity modulated radiotherapy (IMRT), and brachytherapy;J R Evans;Radiother Oncol,2015
4. Health-related quality of life after stereotactic body radiation therapy for localized prostate cancer: results from a multi-institutional consortium of prospective trials;C R King;International Journal of Radiation Oncology,2013
5. Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial;A C Tree;The Lancet Oncology,2022